SUGISHITA DAVID 4

4 · IMMERSION CORP · Filed Dec 3, 2018

Form 4

Period: 2018-11-29

Director

Transactions

Sale
Common Stock
2018-11-29$9.62/sh−35,328$339,862→ 46,808 total
Sale
Common Stock
2018-11-30$9.50/sh−14,245$135,372→ 34,552 total
Exercise/Conversion
Common Stock
2018-12-03$5.53/sh+400$2,212→ 34,952 total
Sale
Common Stock
2018-12-03$9.51/sh−100$951→ 34,852 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2018-11-30−1,989→ 2,295 total
Exercise: $5.53Exp: 2020-07-14→ Common Stock (1,989 underlying)
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2018-12-03−400→ 1,895 total
Exercise: $5.53Exp: 2020-07-14→ Common Stock (400 underlying)
Exercise/Conversion
Common Stock
2018-11-29$5.53/sh+6,550$36,222→ 82,136 total
Exercise/Conversion
Common Stock
2018-11-30$5.53/sh+1,989$10,999→ 48,797 total
Sale
Common Stock
2018-12-03$9.50/sh−600$5,700→ 34,252 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2018-11-29−6,550→ 4,284 total
Exercise: $5.53Exp: 2020-07-14→ Common Stock (6,550 underlying)

Footnotes (4)

[F1]Represents the aggregate of sales effected on the same day at different prices.
[F2]Represents the weighted average sales price per share. The shares sold at prices ranging from $9.60 to $9.71 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
[F3]Represents the weighted average sales price per share. The shares sold at prices ranging from $9.50 to $9.61 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
[F4]25% of the shares vested and became exercisable on June 4, 2011; then 2.0833% of the shares vested and became exercisable monthly thereafter until 100% vested.

Documents

1 file